Factors associated with patient preferences for disease-modifying therapies in multiple sclerosis
AL Hincapie, J Penm, CF Burns - Journal of Managed Care & Specialty …, 2017 - jmcp.org
BACKGROUND: Treatment adherence in patients with multiple sclerosis (MS) is essential to
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …
Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis
AL Hincapie, J Penm, CF Burns - Journal of managed …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Treatment adherence in patients with multiple sclerosis (MS) is essential to
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …
Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis.
AL Hincapie, J Penm, CF Burns - Journal of Managed Care & …, 2017 - europepmc.org
Background Treatment adherence in patients with multiple sclerosis (MS) is essential to
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …
[HTML][HTML] Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis
AL Hincapie, J Penm, CF Burns - Journal of Managed Care & …, 2017 - ncbi.nlm.nih.gov
BACKGROUND: Treatment adherence in patients with multiple sclerosis (MS) is essential to
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …